M
Melanoma Research Alliance
Biotech & Life Sciences · United States · Founded 2007
The Melanoma Research Alliance exists to accelerate treatment options and find a cure for melanoma MoreLess
The Melanoma Research Alliance (MRA) is a public charity committed to advancing the fight against melanoma.
As the largest non-profit funder of melanoma research globally, MRA's primary activity is providing grants for scientific investigation. The organization has invested over $150 million, supporting more than 440 grant awards. Its funding strategy is comprehensive, covering a wide spectrum of research areas, including prevention, diagnosis, and treatment of melanoma.
MRA operates on a collaborative model, forming partnerships with individuals, private foundations, and corporations to amplify its impact. These collaborations are crucial for funding a diverse portfolio of research projects, from individual investigator-led studies to large-scale, multi-institutional team science projects.
In addition to research funding, the organization provides a range of support resources for patients and their families. This includes the Melanoma > Exchange, an online community platform where individuals affected by melanoma can connect, share experiences, and find support. MRA also offers educational materials and resources to help patients navigate their diagnosis and treatment options.
Keywords: melanoma research, nonprofit funder, grant awards, scientific investigation, cancer research, patient support, collaborative partnerships, medical research, oncology, dermatology
Company overview
Melanoma Research Alliance company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2007
- Headquarters
- United States
- Employees
- 22
- Open positions
- 3
- Dealroom signal
- 63.4
Valuation & funding
Melanoma Research Alliance funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCEquity / VC | Nov 2019 | $20M | $80M | Undisclosed | — |
| LATE VC✓Equity / VC | Nov 2017 | $20M | $80M | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 22 |
| 2025 | 24 |
| 2024 | 25 |
| 2023 | 25 |
| 2022 | 23 |
| 2021 | 21 |
| 2020 | 20 |
Growth signals
Melanoma Research Alliance website traffic
Latest recorded traffic for Melanoma Research Alliance is 57K monthly website visits, up 9.6% over the last three months. Melanoma Research Alliance's team declined 8.3% over the past year.
Hiring
Open positions at Melanoma Research Alliance
Current openings linked to this company in Dealroom.
Comparisons
Melanoma Research Alliance compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Melanoma Research Alliance's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Melanoma Research Alliance has talent and traffic
team presence
In the news
Latest news about Melanoma Research Alliance
Recent press, funding announcements, and product moves mentioning Melanoma Research Alliance — open to read from the original sources.
Market sentiment
What the market is saying about Melanoma Research Alliance
An AI-synthesized read of the highest-engagement posts about Melanoma Research Alliance on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Melanoma Research Alliance’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.